These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 19264533)

  • 1. Biocatalysis in development of green pharmaceutical processes.
    Tao J; Xu JH
    Curr Opin Chem Biol; 2009 Feb; 13(1):43-50. PubMed ID: 19264533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocatalytic routes to chiral amines and amino acids.
    Gotor-Fernández V; Gotor V
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):784-97. PubMed ID: 19894190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroformylation and carbonylation processes: new trends in the synthesis of pharmaceuticals.
    Chaudhari RV
    Curr Opin Drug Discov Devel; 2008 Nov; 11(6):820-8. PubMed ID: 18946846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalable enantioselective processes for chiral pharmaceutical intermediates.
    Iida T; Mase T
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):834-51. PubMed ID: 12478715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of biotransformations and biocatalysis to complexity generation in organic synthesis.
    Hudlicky T; Reed JW
    Chem Soc Rev; 2009 Nov; 38(11):3117-32. PubMed ID: 19847346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the development of new biocatalytic processes for practical pharmaceutical synthesis.
    Huisman GW; Collier SJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):284-92. PubMed ID: 23462589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.
    Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM
    Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation processes for organic molecules using SCF Technologies.
    Daintree LS; Kordikowski A; York P
    Adv Drug Deliv Rev; 2008 Feb; 60(3):351-72. PubMed ID: 18006179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.
    Cervera-Padrell AE; Skovby T; Kiil S; Gani R; Gernaey KV
    Eur J Pharm Biopharm; 2012 Oct; 82(2):437-56. PubMed ID: 22820647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applied biotransformations in green solvents.
    Hernáiz MJ; Alcántara AR; García JI; Sinisterra JV
    Chemistry; 2010 Aug; 16(31):9422-37. PubMed ID: 20669193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocatalytic synthesis of enantiopure building blocks for pharmaceuticals.
    Simon RC; Mutti FG; Kroutil W
    Drug Discov Today Technol; 2013; 10(1):e37-44. PubMed ID: 24050228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in industrial biocatalysis.
    Nestl BM; Nebel BA; Hauer B
    Curr Opin Chem Biol; 2011 Apr; 15(2):187-93. PubMed ID: 21195018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocatalysis for the production of carbohydrate esters.
    Chang SW; Shaw JF
    N Biotechnol; 2009 Oct; 26(3-4):109-16. PubMed ID: 19628056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of green chemistry in process research and development.
    Dunn PJ
    Chem Soc Rev; 2012 Feb; 41(4):1452-61. PubMed ID: 21562677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of incomplete removal of the tert-butoxycarbonyl protecting group during synthesis of a pharmaceutical drug substance on the residual solvent analysis.
    Beilin E; Baker LJ; Aikins J; Baryla NE
    J Pharm Biomed Anal; 2010 Jun; 52(2):316-9. PubMed ID: 20116957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective functionalization of small organic molecules using electrophilic nitrogen sources.
    Watson ID; Yudin AK
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):906-17. PubMed ID: 12478721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.